LIÑAN RICO, ANDROMEDA

LIÑAN RICO, ANDROMEDA

CIENCIAS BIOMÉDICAS · Nivel 1

enteric glial cells purinergic signaling myenteric neuron gut inflammation

Información*

Nombre ANDROMEDA LIÑAN RICO
Área BIOLOGÍA Y QUÍMICA
Campo CIENCIAS BIOMÉDICAS
Disciplina FARMACOLOGÍA HUMANA
Especialidad SEÑALIZACION
CVU 39129
Institución
Dependencia NO APLICA
Entidad NO APLICA
Nivel 1
Vigencia Inicio: 01/01/2022
Fin: 31/12/2026

* Información del primer trimestre de 2026.
Fuente: SECIHTI.

Publicaciones ORCID

2026
Decreased Excitability and Voltage‐Gated Sodium Currents in Myenteric Neurons Contribute to the Impairment of Gut Contraction in Type 2 Diabetes Mice Neurogastroenterology & Motility
2025
Obesogenic cafeteria diet induces dynamic changes in gut microbiota, reduces myenteric neuron excitability, and impairs gut contraction in mice AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
2024
Pharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes Pharmaceuticals
Gene expression alterations of purinergic signaling components in obesity-associated intestinal low-grade inflammation in type 2 diabetes PURINERGIC SIGNALLING
2023
Mini-review: Enteric glial cell reactions to inflammation and potential therapeutic implications for GI diseases, motility disorders, and abdominal pain NEUROSCIENCE LETTERS
2020
An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV-2) JOURNAL OF MEDICAL VIROLOGY
First report of begomoviruses infecting <i>Cucumis sativus</i> L. in North America and identification of a proposed new begomovirus species PEERJ
2019
Tamoxifen induces toxicity, causes autophagy, and partially reverses dexamethasone resistance in Jurkat T cells JOURNAL OF LEUKOCYTE BIOLOGY
2017
UTP - Gated Signaling Pathways of 5-HT Release from BON Cells as a Model of Human Enterochromaffin Cells FRONTIERS IN PHARMACOLOGY
2016
Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases INFLAMMATORY BOWEL DISEASES